Superior Planning LLC’s Design Therapeutics DSGN Stock Holding History
Bought
Maintained
Sold
Other funds holding DSGN
Superior Planning LLC's DSGN Position: Q3 2026 in Review
Superior Planning LLC opened a new position in Design Therapeutics (DSGN) in Q3 2026: 260 shares worth $3.27K. The stake represents ﹤0.01% of the portfolio and ranks #1371 among its holdings.
97 funds tracked by Wall St. Rank hold DSGN as of Q3 2026.
- Superior Planning LLC held 260 shares of Design Therapeutics worth $3.27K as of Q3 2026.
- Design Therapeutics was a new Superior Planning LLC position in Q3 2026.
- Design Therapeutics made up ﹤0.01% of Superior Planning LLC's portfolio in Q3 2026, its #1371 holding.
- 97 funds tracked by Wall St. Rank held Design Therapeutics as of Q3 2026.
Based on Superior Planning LLC's 13F filing for Q3 2026, filed 12 Nov 2026.